AGL agilon health, inc.
agilon health, inc. (AGL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: March 9, 2026 , by Venkatachaliah Girish .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Venkatachaliah Girish | Chief Technology Officer | Buy | 18,448 | $0.00 | $0 | 285,084 | |
| Shaker Benjamin | Chief Markets Officer | Buy | 18,448 | $0.00 | $0 | 1,386,122 | |
| Zamore Denise | Chief Legal Officer | Buy | 5,535 | $0.00 | $0 | 448,660 | |
| Shaker Benjamin | Chief Markets Officer | Buy | 500,000 | $0.60 | $301.1K | 1,367,674 | |
| Wulf John William | Director | Buy | 81,000 | $0.63 | $50.9K | 365,857 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.